Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.340
+0.030 (0.91%)
At close: Sep 11, 2026, 4:00 PM EDT
3.400
+0.060 (1.80%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Adagene Employees
Adagene had 128 employees as of December 31, 2025. The number of employees decreased by 10 or -7.25% compared to the previous year.
Employees
128
Change (1Y)
-10
Growth (1Y)
-7.25%
Revenue / Employee
$72,584
Profits / Employee
-$160,242
Market Cap
224.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | -10 | -7.25% |
| Dec 31, 2024 | 138 | -36 | -20.69% |
| Dec 31, 2023 | 174 | -74 | -29.84% |
| Dec 31, 2022 | 248 | -11 | -4.25% |
| Dec 31, 2021 | 259 | 61 | 30.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Invivyd | 122 |
| Keros Therapeutics | 92 |
| Neumora Therapeutics | 63 |
| Protara Therapeutics | 46 |
| Surrozen | 44 |
| Eledon Pharmaceuticals | 33 |
| Sol-Gel Technologies | 28 |
ADAG News
- 1 day ago - Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology - GlobeNewsWire
- 1 day ago - Adagene initiated with a Buy at Chardan - TheFly
- 2 days ago - Adagene announces $2M milestone payment from Exelixis - TheFly
- 2 days ago - Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates - GlobeNewsWire
- 22 days ago - Adagene to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Adagene Earnings release: Q2 2026 - Filings
- 4 weeks ago - Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 2 months ago - Adagene Slides: Corporate presentation - Filings